Michael Klichinsky
Founder at CARISMA THERAPEUTICS, INC.
Net worth: 794 329 $ as of 2024-04-29
Michael Klichinsky active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-03-31 | - |
| Founder | 2015-12-31 | - | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 2022-03-31 | - |
| Founder | 2015-12-31 | - | |
| Corporate Officer/Principal | 2018-09-30 | 2022-03-31 |
Career history of Michael Klichinsky
Training of Michael Klichinsky
| University of Pennsylvania | Doctorate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Michael Klichinsky
- Experience